Evidence map›Paper›PMID 26577415›Full record

Trial reportDiabetes care2016

Relationship Between Parental Diabetes and Presentation of Metabolic and Glycemic Function in Youth With Type 2 Diabetes: Baseline Findings From the TODAY Trial.

Steven D Chernausek, Silva Arslanian, Sonia Caprio, Kenneth C Copeland, Laure El ghormli, Megan M Kelsey, Michaela B Koontz, Carisse M Orsi, Denise Wilfley

Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Diabetes care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00081328. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00081328 phase3completed

Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Clinical Trial

Ran2004Enrolled699Registered outcomes11Posted comparisons0ConditionsDiabetes Mellitus, Type IIArmsLifestyle Program, Metformin, Rosiglitazone
Open the trial in the graph
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Insulin resistance and type 2 diabetes in children.Annals of pediatric endocrinology & metabolism · 2020
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Cardiometabolic risk in obese children.Annals of the New York Academy of Sciences · 2018
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Steven D ChernausekDepartment of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Silva ArslanianChildren's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, PA.
Sonia CaprioDepartment of Pediatrics, Yale University School of Medicine, New Haven, CT.
Kenneth C CopelandDepartment of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Laure El ghormliThe George Washington University Biostatistics Center, Rockville, MD elghorml@bsc.gwu.edu.
Megan M KelseyDepartment of Endocrinology, University of Colorado School of Medicine, Aurora, CO.
Michaela B KoontzDepartment of Pediatrics, School of Medicine, Case Western Reserve University, Cleveland, OH.
Carisse M OrsiUniversity of Texas Health Science Center at San Antonio, San Antonio, TX.
Denise WilfleyDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO.
George Washington University · USUniversity of Oklahoma Health Sciences Center · USCase Western Reserve University · USThe University of Texas Health Science Center at San Antonio · USUniversity of Pittsburgh Medical Center · USWashington University in St. Louis · USYale University · US

Funding

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) StudyU01DK061230 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI BRAFFETT, BARBARA HALINA, ZEITLER, PHILIP S. · 2001 to 2019
$231.8M
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
ZOPOLRESTAT IN NORMOTENSIVE, TYPE 1 DIA WITH INCIPIENT NEPHROPATHYM01RR000043 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PULIAFITO, CARMEN A · 1985 to 2010
$76.4M
UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
ZD6416 Analgesic--Painful Distal Symmetrical PolyneuropaM01RR001066 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI GRINSPOON, STEVEN K. · 1985 to 2008
$37.4M
NCATS NIH HHS UL1 TR000439NCATS NIH HHS UL1 TR000448NCRR NIH HHS M01 RR000036NCRR NIH HHS M01-RR-000036NCRR NIH HHS M01 RR000043NCRR NIH HHS M01-RR-000043-45NCRR NIH HHS M01 RR000069NCRR NIH HHS M01-RR-000069NCRR NIH HHS M01 RR000084NCRR NIH HHS M01-RR-000084NCRR NIH HHS M01 RR000125NCRR NIH HHS M01-RR-000125NCRR NIH HHS M01 RR001066NCRR NIH HHS M01-RR-001066NCRR NIH HHS M01 RR014467NCRR NIH HHS M01-RR-014467NCRR NIH HHS UL1 RR024134NCRR NIH HHS UL1-RR-024134NCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1-RR-024139NCRR NIH HHS UL1 RR024153NCRR NIH HHS UL1-RR-024153NCRR NIH HHS UL1 RR024989NCRR NIH HHS UL1-RR-024989NCRR NIH HHS UL1 RR024992NCRR NIH HHS UL1-RR-024992NCRR NIH HHS UL1 RR025758NCRR NIH HHS UL1-RR-025758NCRR NIH HHS UL1 RR025780NCRR NIH HHS UL1-RR-025780NIDDK NIH HHS U01 DK061212NIDDK NIH HHS U01-DK-061212NIDDK NIH HHS U01 DK061230NIDDK NIH HHS U01-DK-061230NIDDK NIH HHS U01 DK061239NIDDK NIH HHS U01-DK-061239NIDDK NIH HHS U01 DK061242NIDDK NIH HHS U01-DK-061242NIDDK NIH HHS U01 DK061254NIDDK NIH HHS U01-DK-061254
6 · The paper itself

Abstract

objectiveChildren whose parents have diabetes are at increased risk for developing type 2 diabetes. This report assessed relationships between parental diabetes status and baseline demographics, anthropometrics, metabolic measurements, insulin sensitivity, and β-cell function in children recently diagnosed with type 2 diabetes. RESEARCH DESIGN AND

methodsThe sample included 632 youth (aged 10-17 years) diagnosed with type 2 diabetes for <2 years who participated in the TODAY clinical trial. Medical history data were collected at baseline by self-report from parents and family members. Youth baseline measurements included an oral glucose tolerance test and other measures collected by trained study staff.

resultsYouth exposed to maternal diabetes during pregnancy (whether the mother was diagnosed with diabetes prior to pregnancy or had gestational diabetes mellitus) were diagnosed at younger ages (by 0.6 years on average), had greater dysglycemia at baseline (HbA1c increased by 0.3% [3.4 mmol/mol]), and had reduced β-cell function compared with those not exposed (C-peptide index 0.063 vs. 0.092). The effect of maternal diabetes on β-cell function was observed in non-Hispanic blacks and Hispanics but not whites. Relationships with paternal diabetes status were minimal.

conclusionsMaternal diabetes prior to or during pregnancy was associated with poorer glycemic control and β-cell function overall but particularly in non-Hispanic black and Hispanic youth, supporting the hypothesis that fetal exposure to aberrant metabolism may have long-term effects. More targeted research is needed to understand whether the impact of maternal diabetes is modified by racial/ethnic factors or whether the pathway to youth-onset type 2 diabetes differs by race/ethnicity.

Indexed as

AdolescentBlack or African AmericanBlood GlucoseChildC-PeptideDiabetes, GestationalDiabetes Mellitus, Type 2EthnicityFamily HealthFemaleGlucose Tolerance TestHispanic or LatinoHumansHyperglycemiaInsulin ResistanceInsulin-Secreting CellsBlood GlucoseC-Peptide

Identifiers

PMID26577415
PMCPMC4686846
OpenAlexW2208158729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.